Anaplastic Large Cell Lymphoma — Trials

Anaplastic Large Cell Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

183 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 14
Ph III recruiting: 3
Growth YoY: —
Industry share: 15%
Top sponsor: City of Hope Medical Center
Termination share: 26.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (33)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04058470	Toripalimab Plus Rituximab Followed by R-CHOP for Elderly Patients With Untreated Diffused B Cell Lymphoma	unknown	Phase 1 / Phase 2	140	Huiqiang HuangOTHER	1	Apr 14, 2022	clinicaltrials
NCT04476459	Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL	unknown	Phase 1 / Phase 2	33	Huiqiang HuangOTHER	1	Mar 15, 2021	clinicaltrials